TAXUS PHARMACEUTICALS HOLDINGS, INC. — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2017)

$5.9K

Net Income/Loss (FY2017)

-$117.0K

Total Assets (FY2017)

$8.9K

Total Equity (FY2017)

-$53.7K

Cash Flows from Operating Activities (FY2017)

-$98.8K

Source: TAXUS PHARMACEUTICALS HOLDINGS, INC. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.